| |
|
|
|
Cymabay Therapeutics  
|
|
12.26 -0.04 (-0%) |
04-24 11:57 |
|
Open: |
12.46 |
Pre close: |
12.3 |
Target:
|
15.51
|
|
High: |
12.6836 |
Low: |
12.23 |
Resistance:
|
13.28
15.00
|
|
Volume: |
169,786 |
Market Cap: |
717M |
Support:
|
10.50
8.74
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
12.88
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
12.36 |
Signal(12,26,9): |
-0.07  |
|
MA(100): |
11.57 |
Stochastic Oscillator |
%K(14,3):
|
48.74 |
|
MA(250): |
8.54 |
%D(3): |
55.28 |
|
Average Volume(K) |
3-Month: |
130467
|
52-Week |
High:
|
15.59 |
|
10-Days: |
198027 |
Low: |
3.16 |
|
RSI |
RSI(14):
|
46.82 |
Change(%): |
267.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.830 |
Return on Equity (ttm) |
-62.0 |
Shares Out. (M) |
58.50 |
|
EPS Est. Current Year |
-0.820 |
Return on Assets (ttm) |
-44.6 |
Shares Float (M) |
58.12 |
|
EPS Est. Next Year |
-0.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.90 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
60.90 |
|
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2466 |
|
Book Value (p.s.) |
9.170 |
EBITDA (p.s.) |
-0.370 |
P/E |
-14.87 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.35 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-19.63 |
P/S |
2489275904.00 |
|
Operating Margin |
-187.25 |
Levered Free Cash Flow
(M) |
-5.22 |
P/CF |
-36.78 |
|
|
|
|
|
|
